Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ASTE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
YIPF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC15A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PWP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CBL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MICU1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C19orf12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BET1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SFSWAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HEMK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KAT5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC19A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASAL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC26A6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPDPF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RANGRF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on